TraceLink Omnicell DSCSA Integration
Analysis based on 8 articles · First reported Jul 20, 2026 · Last updated Sep 03, 2026
The integration is expected to strengthen Omnicell's competitive position in hospital pharmacy automation by adding DSCSA compliance capabilities, potentially increasing demand for its systems. For TraceLink, the partnership expands its network reach into hospital pharmacy operations, reinforcing its role as a critical infrastructure provider in the pharmaceutical supply chain.
TraceLink, a life sciences and healthcare supply chain network provider, announced an integration between its Drug Supply Chain Security Act (DSCSA) compliance solution and Omnicell's pharmacy inventory management systems. This integration enables hospitals and health systems to manage product verification, traceability, and compliance directly within their medication receiving workflows, reducing manual effort and eliminating disconnected compliance processes. The solution leverages TraceLink's Integrate-Once Agentic Business Network, which connects over 315,000 authenticated entities and supports hundreds of billions of annual supply chain transactions. By embedding DSCSA capabilities into Omnicell Central Pharmacy Manager workflows, pharmacy teams can verify serialized products, resolve exceptions, and complete compliance reporting more efficiently. The integration aims to improve operational efficiency, support medication safety, and enable faster response to recalls. Executives from both companies, Shabbir Dahod of TraceLink and Sundar Tamma of Omnicell, highlighted the benefits of reducing compliance burden while maintaining efficient pharmacy operations.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard